![Datuk Abd Hapiz bin Abdullah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Datuk Abd Hapiz bin Abdullah
Consultant / Advisor chez
Xeraya Capital Sdn. Bhd.
Profil
Datuk Abd Hapiz bin Abdullah is currently a venture Partner at Xeraya Capital Sdn.
Bhd.
He previously worked as the President & Chief Executive Officer at PETRONAS Chemicals Group Bhd.
He graduated from Utah State University.
Postes actifs de Datuk Abd Hapiz bin Abdullah
| Sociétés | Poste | Début |
|---|---|---|
Xeraya Capital Sdn. Bhd.
 Xeraya Capital Sdn. Bhd. Investment ManagersFinance Xeraya Capital invests in life science companies located across the Globe primarily in united states< Europe and Asia. The firm focuses on companies operating in the fields of medical technologies, pharmaceutical biotech and biorenewables, agtech & others. They provide financing for early stage capital requirements and also takes minority equity positions. | Consultant / Advisor | 01/01/2015 |
Anciens postes connus de Datuk Abd Hapiz bin Abdullah
| Sociétés | Poste | Fin |
|---|---|---|
| PETRONAS CHEMICALS GROUP | Directeur Général | - |
Formation de Datuk Abd Hapiz bin Abdullah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Utah State University
 Utah State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PETRONAS Chemicals Group Bhd.
 PETRONAS Chemicals Group Bhd. Chemicals: SpecialtyProcess Industries Manufactures and markets petrochemical products | Process Industries |
Xeraya Capital Sdn. Bhd.
Xeraya Capital Sdn. Bhd. Investment ManagersFinance Xeraya Capital invests in life science companies located across the Globe primarily in united states< Europe and Asia. The firm focuses on companies operating in the fields of medical technologies, pharmaceutical biotech and biorenewables, agtech & others. They provide financing for early stage capital requirements and also takes minority equity positions. | Finance |
